GlassScriptPhysician profile
Jeffrey H Johnson
NPI 1942869250
$2,020.36
in general payments reported to CMS, 2019-2025
11 companies · $260 in 2025
The $260 reported for 2025 was more than what 81% of General Practice (Dentist) providers received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $207 · 2021: $508 · 2022: $476 · 2023: $496 · 2024: $72.77 · 2025: $260.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Gift: $660 · Food and Beverage: $168.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Gift | $660.46 |
| Food and Beverage | $168.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ultradent Products INC | $1,058.30 | 2022-2025 | Opalescence |
| Straumann USA LLC | $427.17 | 2021 | |
| Kerr Corporation | $123.93 | 2020 | |
| Nobel Biocare USA | $92.24 | 2023 | Nobelactive |
| Salvin Dental Specialties, INC. | $83.33 | 2020 | |
| Dentsply Sirona INC | $81.18 | 2021 | |
| Patterson Companies, INC. | $64.04 | 2022-2024 | |
| Align Technology, INC. | $34.60 | 2022 | |
| Revance Therapeutics, INC. | $24.06 | 2024 | Daxxify |
| Kuros Biosciences USA, INC | $17.46 | 2022 | |
| Colgate Oral Pharmaceuticals, INC. | $14.05 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.